A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAddario Lung Cancer Medical Institute

About this trial

This is a multi-center observational study in subjects with a diagnosis of small cell lung cancer. Screening and/or medical record review for symptoms associated with Lambert Eaton Myasthenic Syndrome (LEMS) will be conducted.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult men or women meeting Age of Majority (AOM) at the time of consent

Provide voluntary consent to participate in this study, documented via a signed informed Consent Form (ICF)

Any diagnosis of SCLC

Willing to provide clinical and medical information related to his/her cancer diagnoses to the study team as required

Disqualifiers

Has been diagnosed with non-tumor Lamber-Eaton Myasthenic syndrome (LEMS) > 1 year prior to the SCLC diagnosis.

Known existence of an uncontrolled intercurrent illness including, but not limited to, psychiatric illness or social situations that would impair compliance with study requirements

Trial population

United States

Trial design

Design model

Case-only

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

400 Participants
are grouped into 1 trial group
Group A: SCLC

Trial outcomes

Primary outcomes

1

Suspicious LEMS

Incidence of clinically suspicious LEMS diagnosis

Time frame
1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: